检索结果 - Siddhartha Goutam

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

    Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells 由 Nicholas Jette, Suraj Radhamani, Greydon Arthur, Ruiqiong Ye, Siddhartha Goutam, Anthony Bolyos, Lars F. Petersen, Pinaki Bose, D. Gwyn Bebb, Susan P. Lees‐Miller

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    ATM-Deficient Cancers Provide New Opportunities for Precision Oncology

    ATM-Deficient Cancers Provide New Opportunities for Precision Oncology 由 Nicholas Jette, Mehul Kumar, Suraj Radhamani, Greydon Arthur, Siddhartha Goutam, Steven Yip, Michael Paul Kolinsky, Gareth J. Williams, Pinaki Bose, Susan P. Lees‐Miller

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy

    Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Im... 由 Alexander Watson, Siddhartha Goutam, Igor Stukalin, Benjamin W. Ewanchuk, Michael Sander, Daniel E. Meyers, Aliyah Pabani, Winson Y. Cheung, Daniel Y.C. Heng, Tina Cheng, Jose Gerard Monzon, Vishal Navani

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors

    Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors 由 Daniel E. Meyers, Meghann Pasternak, Samantha Dolter, Heidi A.I. Grosjean, Chloe Lim, Igor Stukalin, Siddhartha Goutam, Vishal Navani, Daniel Yick Chin Heng, Winson Y. Cheung, Don Morris, Aliyah Pabani

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

    Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials 由 Chun Loo Gan, Igor Stukalin, Daniel E. Meyers, Shaan Dudani, Heidi A.I. Grosjean, Samantha Dolter, Benjamin W. Ewanchuk, Siddhartha Goutam, Michael Sander, J. Connor Wells, Aliyah Pabani, Tina Cheng, Jose Gerard Monzon, Don Morris, Naveen S. Basappa, Sumanta K. Pal, Lori Wood, Frede Donskov, Toni K. Choueiri, Daniel Y.C. Heng

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: